tiprankstipranks
Trending News
More News >
Avantor (AVTR)
:AVTR
US Market
Advertisement

Avantor (AVTR) Stock Forecast & Price Target

Compare
443 Followers
See the Price Targets and Ratings of:

AVTR Analyst Ratings

Moderate Buy
17Ratings
Moderate Buy
8 Buy
9 Hold
0 Sell
Based on 17 analysts giving stock ratings to
Avantor
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

AVTR Stock 12 Month Forecast

Average Price Target

$14.87
▲(27.75% Upside)
Based on 17 Wall Street analysts offering 12 month price targets for Avantor in the last 3 months. The average price target is $14.87 with a high forecast of $30.00 and a low forecast of $12.00. The average price target represents a 27.75% change from the last price of $11.64.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"10":"$10","31":"$31","15.25":"$15.25","20.5":"$20.5","25.75":"$25.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":30,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$30.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":14.87,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$14.87</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":12,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$12.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[10,15.25,20.5,25.75,31],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2024","6":"Feb<br/>2025","9":"May<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,11.36,12.793846153846154,14.227692307692308,15.661538461538461,17.095384615384617,18.52923076923077,19.963076923076922,21.396923076923077,22.83076923076923,24.264615384615386,25.69846153846154,27.13230769230769,28.566153846153846,{"y":30,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,11.36,11.629999999999999,11.899999999999999,12.17,12.44,12.709999999999999,12.979999999999999,13.25,13.52,13.79,14.059999999999999,14.329999999999998,14.599999999999998,{"y":14.87,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,11.36,11.409230769230769,11.458461538461538,11.507692307692308,11.556923076923077,11.606153846153846,11.655384615384616,11.704615384615384,11.753846153846153,11.803076923076922,11.852307692307692,11.901538461538461,11.95076923076923,{"y":12,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":26.5,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25.84,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25.42,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.31,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.1,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.07,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.28,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.7,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.8,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.96,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.96,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.92,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.36,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$30.00Average Price Target$14.87Lowest Price Target$12.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on AVTR
TipRanks AITipRanks
Not Ranked
TipRanks
$12
Hold
3.09%
Upside
Reiterated
08/02/25
Avantor's overall score is driven by solid financials and a strategic leadership change, despite technical weakness and lowered earnings guidance. The company's low P/E ratio and cash flow strength provide valuation support, while operational challenges and a competitive environment weigh on the outlook.
Wells Fargo
$19$16
Buy
37.46%
Upside
Reiterated
08/04/25
Analysts' Opinions Are Mixed on These Healthcare Stocks: Bausch + Lomb Corporation (NYSE: BLCO), Avantor (NYSE: AVTR) and AptarGroup (NYSE: ATR)
UBS
$14$13
Hold
11.68%
Upside
Reiterated
08/04/25
Avantor (AVTR) Receives a Hold from UBSUBS analyst Dan Leonard lowered the price target on Avantor Inc. (NYSE: AVTR) to $13.00 (from $14.00) while maintaining a Neutral rating.
Robert W. Baird
$18$15
Buy
28.87%
Upside
Reiterated
08/04/25
Avantor price target lowered to $15 from $18 at BairdAvantor price target lowered to $15 from $18 at Baird
Citi
$14$13
Hold
11.68%
Upside
Reiterated
08/04/25
Analysts' Top Healthcare Picks: Moderna (MRNA), Centene (CNC)
Morgan Stanley Analyst forecast on AVTR
Patrick WoodMorgan Stanley
Morgan Stanley
$15$12
Hold
3.09%
Upside
Reiterated
08/04/25
Analysts Offer Insights on Healthcare Companies: Regeneron (NASDAQ: REGN), Eli Lilly & Co (NYSE: LLY) and Avantor (NYSE: AVTR)We decrease our PT to $12 from $15, using a target EV/26E EBITDA multiple of ~10x, a discount to Core Tools peers, which we view as justified in light of slower sales growth and lower EBITDA margins. Key takes from the call: 1. Although Lab Solutions revenue was in line with expectations, the Company continues to face high levels of competitive intensity, driven by the challenging funding and policy-related environment. Mgmt noted that this headwind is most pronounced among large biopharma accounts. The Company is implementing several actions in Lab Solutions to protect and grow market share, including leveraging pricing as a tool. The recent strategic initiatives have negatively impacted segment margins in 2Q, and are expected to continue pressuring margins in the near future.
J.P. Morgan Analyst forecast on AVTR
Rachel VatnsdalJ.P. Morgan
J.P. Morgan
$14
Buy
20.27%
Upside
Reiterated
08/04/25
J.P. Morgan Remains a Buy on Avantor (AVTR)
Bernstein Analyst forecast on AVTR
Eve BursteinBernstein
Bernstein
$15$13
Hold
11.68%
Upside
Reiterated
08/04/25
Avantor (AVTR) Receives a Hold from Bernstein
William Blair Analyst forecast on AVTR
Matt LarewWilliam Blair
William Blair
Hold
Assigned
08/04/25
William Blair Remains a Hold on Avantor (AVTR)
Stifel Nicolaus Analyst forecast on AVTR
Daniel AriasStifel Nicolaus
Stifel Nicolaus
$14$12
Hold
3.09%
Upside
Reiterated
08/04/25
Avantor (AVTR) Gets a Hold from Stifel Nicolaus2Q25 Review: Goin' Downthe Road Feelin' Bad – we maintain our Hold rating.
Raymond James Analyst forecast on AVTR
Andrew CooperRaymond James
Raymond James
$14
Buy
20.27%
Upside
Reiterated
08/04/25
Raymond James Remains a Buy on Avantor (AVTR)
Barclays Analyst forecast on AVTR
Luke SergottBarclays
Barclays
$15$13
Buy
11.68%
Upside
Reiterated
08/04/25
Analysts Offer Insights on Healthcare Companies: Avantor (NYSE: AVTR), Nuvalent (NASDAQ: NUVL) and Alphatec Holdings (NASDAQ: ATEC)
TD Cowen
$15.5$13
Hold
11.68%
Upside
Reiterated
08/01/25
Avantor's Market Uncertainty: Hold Rating Amid Pricing Pressures and Leadership Transition
Jefferies
$12
Hold
3.09%
Upside
Downgraded
08/01/25
Avantor downgraded to Hold from Buy at JefferiesAvantor downgraded to Hold from Buy at Jefferies
RBC Capital Analyst forecast on AVTR
Conor McNamaraRBC Capital
RBC Capital
$20$17
Buy
46.05%
Upside
Reiterated
08/01/25
RBC Capital Remains a Buy on Avantor (AVTR)
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on AVTR
TipRanks AITipRanks
Not Ranked
TipRanks
$12
Hold
3.09%
Upside
Reiterated
08/02/25
Avantor's overall score is driven by solid financials and a strategic leadership change, despite technical weakness and lowered earnings guidance. The company's low P/E ratio and cash flow strength provide valuation support, while operational challenges and a competitive environment weigh on the outlook.
Wells Fargo
$19$16
Buy
37.46%
Upside
Reiterated
08/04/25
Analysts' Opinions Are Mixed on These Healthcare Stocks: Bausch + Lomb Corporation (NYSE: BLCO), Avantor (NYSE: AVTR) and AptarGroup (NYSE: ATR)
UBS
$14$13
Hold
11.68%
Upside
Reiterated
08/04/25
Avantor (AVTR) Receives a Hold from UBSUBS analyst Dan Leonard lowered the price target on Avantor Inc. (NYSE: AVTR) to $13.00 (from $14.00) while maintaining a Neutral rating.
Robert W. Baird
$18$15
Buy
28.87%
Upside
Reiterated
08/04/25
Avantor price target lowered to $15 from $18 at BairdAvantor price target lowered to $15 from $18 at Baird
Citi
$14$13
Hold
11.68%
Upside
Reiterated
08/04/25
Analysts' Top Healthcare Picks: Moderna (MRNA), Centene (CNC)
Morgan Stanley Analyst forecast on AVTR
Patrick WoodMorgan Stanley
Morgan Stanley
$15$12
Hold
3.09%
Upside
Reiterated
08/04/25
Analysts Offer Insights on Healthcare Companies: Regeneron (NASDAQ: REGN), Eli Lilly & Co (NYSE: LLY) and Avantor (NYSE: AVTR)We decrease our PT to $12 from $15, using a target EV/26E EBITDA multiple of ~10x, a discount to Core Tools peers, which we view as justified in light of slower sales growth and lower EBITDA margins. Key takes from the call: 1. Although Lab Solutions revenue was in line with expectations, the Company continues to face high levels of competitive intensity, driven by the challenging funding and policy-related environment. Mgmt noted that this headwind is most pronounced among large biopharma accounts. The Company is implementing several actions in Lab Solutions to protect and grow market share, including leveraging pricing as a tool. The recent strategic initiatives have negatively impacted segment margins in 2Q, and are expected to continue pressuring margins in the near future.
J.P. Morgan Analyst forecast on AVTR
Rachel VatnsdalJ.P. Morgan
J.P. Morgan
$14
Buy
20.27%
Upside
Reiterated
08/04/25
J.P. Morgan Remains a Buy on Avantor (AVTR)
Bernstein Analyst forecast on AVTR
Eve BursteinBernstein
Bernstein
$15$13
Hold
11.68%
Upside
Reiterated
08/04/25
Avantor (AVTR) Receives a Hold from Bernstein
William Blair Analyst forecast on AVTR
Matt LarewWilliam Blair
William Blair
Hold
Assigned
08/04/25
William Blair Remains a Hold on Avantor (AVTR)
Stifel Nicolaus Analyst forecast on AVTR
Daniel AriasStifel Nicolaus
Stifel Nicolaus
$14$12
Hold
3.09%
Upside
Reiterated
08/04/25
Avantor (AVTR) Gets a Hold from Stifel Nicolaus2Q25 Review: Goin' Downthe Road Feelin' Bad – we maintain our Hold rating.
Raymond James Analyst forecast on AVTR
Andrew CooperRaymond James
Raymond James
$14
Buy
20.27%
Upside
Reiterated
08/04/25
Raymond James Remains a Buy on Avantor (AVTR)
Barclays Analyst forecast on AVTR
Luke SergottBarclays
Barclays
$15$13
Buy
11.68%
Upside
Reiterated
08/04/25
Analysts Offer Insights on Healthcare Companies: Avantor (NYSE: AVTR), Nuvalent (NASDAQ: NUVL) and Alphatec Holdings (NASDAQ: ATEC)
TD Cowen
$15.5$13
Hold
11.68%
Upside
Reiterated
08/01/25
Avantor's Market Uncertainty: Hold Rating Amid Pricing Pressures and Leadership Transition
Jefferies
$12
Hold
3.09%
Upside
Downgraded
08/01/25
Avantor downgraded to Hold from Buy at JefferiesAvantor downgraded to Hold from Buy at Jefferies
RBC Capital Analyst forecast on AVTR
Conor McNamaraRBC Capital
RBC Capital
$20$17
Buy
46.05%
Upside
Reiterated
08/01/25
RBC Capital Remains a Buy on Avantor (AVTR)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Avantor

1 Month
xxx
Success Rate
9/19 ratings generated profit
47%
Average Return
-1.07%
reiterated a xxx
rating 7 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 47.37% of your transactions generating a profit, with an average return of -1.07% per trade.
3 Months
xxx
Success Rate
9/19 ratings generated profit
47%
Average Return
-2.61%
reiterated a xxx
rating 7 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 47.37% of your transactions generating a profit, with an average return of -2.61% per trade.
1 Year
Michael RyskinBank of America Securities
Success Rate
5/15 ratings generated profit
33%
Average Return
-15.43%
reiterated a buy rating 18 days ago
Copying Michael Ryskin's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -15.43% per trade.
2 Years
xxx
Success Rate
2/23 ratings generated profit
9%
Average Return
-29.53%
reiterated a xxx
rating 4 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 8.70% of your transactions generating a profit, with an average return of -29.53% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

AVTR Analyst Recommendation Trends

Rating
Apr 25
May 25
Jun 25
Jul 25
Aug 25
Strong Buy
5
4
6
2
2
Buy
21
14
16
10
14
Hold
11
11
11
11
19
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
37
29
33
23
35
In the current month, AVTR has received 16 Buy Ratings, 19 Hold Ratings, and 0 Sell Ratings. AVTR average Analyst price target in the past 3 months is 14.87.
Each month's total comprises the sum of three months' worth of ratings.

AVTR Financial Forecast

AVTR Earnings Forecast

Next quarter’s earnings estimate for AVTR is $0.23 with a range of $0.22 to $0.27. The previous quarter’s EPS was $0.24. AVTR beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.03% of the time in the same period. In the last calendar year AVTR has Outperformed its overall industry.
Next quarter’s earnings estimate for AVTR is $0.23 with a range of $0.22 to $0.27. The previous quarter’s EPS was $0.24. AVTR beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.03% of the time in the same period. In the last calendar year AVTR has Outperformed its overall industry.

AVTR Sales Forecast

Next quarter’s sales forecast for AVTR is $1.65B with a range of $1.64B to $1.70B. The previous quarter’s sales results were $1.68B. AVTR beat its sales estimates 25.00% of the time in past 12 months, while its overall industry beat sales estimates 47.64% of the time in the same period. In the last calendar year AVTR has Outperformed its overall industry.
Next quarter’s sales forecast for AVTR is $1.65B with a range of $1.64B to $1.70B. The previous quarter’s sales results were $1.68B. AVTR beat its sales estimates 25.00% of the time in past 12 months, while its overall industry beat sales estimates 47.64% of the time in the same period. In the last calendar year AVTR has Outperformed its overall industry.

AVTR Stock Forecast FAQ

What is AVTR’s average 12-month price target, according to analysts?
Based on analyst ratings, Avantor’s 12-month average price target is 14.87.
    What is AVTR’s upside potential, based on the analysts’ average price target?
    Avantor has 27.75% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is AVTR a Buy, Sell or Hold?
          Avantor has a consensus rating of Moderate Buy which is based on 8 buy ratings, 9 hold ratings and 0 sell ratings.
            What is Avantor’s price target?
            The average price target for Avantor is 14.87. This is based on 17 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $30.00 ,the lowest forecast is $12.00. The average price target represents 27.75% Increase from the current price of $11.64.
              What do analysts say about Avantor?
              Avantor’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 17 Wall Streets Analysts.
                How can I buy shares of AVTR?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis